Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06028165

CABG Based on CT-FFR Versus Conventional Coronary Angiography

A Prospective, Randomized Comparison of Coronary Artery Bypass Grafting Based on COmputed Tomography-derived Fractional Flow REserve Versus Angiography (CABG-COREA Trial)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Myongji Hospital · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aims of study are (1) to compare early and 1-year graft patency rates in patients who underwent coronary artery bypass grafting (CABG) based on conventional coronary angiography(CAG) versus cardiac computed tomography(CT)-derived fractional flow reserve(FFR), and (2) to demonstrate difference in clinical outcomes between the 2 groups.

Detailed description

The CABG-COREA trial is designed as a randomized, controlled trial to recruit 96 patients who undergo coronary artery bypass grafting. Patients were randomized by use of a randomization table. Coronary arteries are revascularized based on conventional coronary angiography (quantitative coronary angiography) or cardiac computed tomography-derived fractional flow reserve according to the randomization result. The primary end point is to evaluate early and 1-year postoperative graft patency. The secondary end points are overall survival, freedom from cardiac death and freedom from MACCE(major adverse cardiac or cerebrovascular events).

Conditions

Interventions

TypeNameDescription
PROCEDURECoronary artery bypass grafting based on conventional coronary angiographyRevascularized coronary arteries are decided based on conventional coronary angiography (quantitative coronary angiography)
PROCEDURECoronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.Revascularized coronary arteries are decided based on cardiac computed tomography-derived fractional flow reserve.

Timeline

Start date
2023-10-20
Primary completion
2024-10-01
Completion
2025-10-01
First posted
2023-09-08
Last updated
2024-07-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06028165. Inclusion in this directory is not an endorsement.